JPWO2021024801A1 - - Google Patents

Info

Publication number
JPWO2021024801A1
JPWO2021024801A1 JP2021537688A JP2021537688A JPWO2021024801A1 JP WO2021024801 A1 JPWO2021024801 A1 JP WO2021024801A1 JP 2021537688 A JP2021537688 A JP 2021537688A JP 2021537688 A JP2021537688 A JP 2021537688A JP WO2021024801 A1 JPWO2021024801 A1 JP WO2021024801A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021537688A
Other languages
Japanese (ja)
Other versions
JP7457713B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021024801A1 publication Critical patent/JPWO2021024801A1/ja
Application granted granted Critical
Publication of JP7457713B2 publication Critical patent/JP7457713B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2021537688A 2019-08-02 2020-07-21 軟骨再生促進用組成物 Active JP7457713B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019143144 2019-08-02
JP2019143144 2019-08-02
PCT/JP2020/028306 WO2021024801A1 (ja) 2019-08-02 2020-07-21 軟骨再生促進用組成物

Publications (2)

Publication Number Publication Date
JPWO2021024801A1 true JPWO2021024801A1 (https=) 2021-02-11
JP7457713B2 JP7457713B2 (ja) 2024-03-28

Family

ID=74503458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537688A Active JP7457713B2 (ja) 2019-08-02 2020-07-21 軟骨再生促進用組成物

Country Status (9)

Country Link
EP (1) EP4008401A4 (https=)
JP (1) JP7457713B2 (https=)
KR (1) KR20220042403A (https=)
CN (1) CN114206330A (https=)
AU (1) AU2020324628A1 (https=)
CA (1) CA3147400A1 (https=)
PH (1) PH12022550260A1 (https=)
TW (1) TW202120078A (https=)
WO (1) WO2021024801A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7457353B2 (ja) * 2020-04-28 2024-03-28 学校法人北陸大学 軟骨細胞への分化促進剤、軟骨細胞の増殖促進剤および軟骨基質産生促進剤
US20240390407A1 (en) * 2021-09-17 2024-11-28 Hokuriku University Promoter for differentiation into cartilage cell, cartilage cell propagation promoter, and cartilage matrix production promoter
WO2025031857A1 (en) 2023-08-09 2025-02-13 Basf Se Fungicidal compositions comprising carboxamides
CN117736980B (zh) * 2024-02-20 2024-05-10 广东先康达生物科技有限公司 脂肪间充质干细胞转化成软骨细胞的诱导分化培养基及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002284A (ja) * 2001-11-30 2004-01-08 Ezaki Glico Co Ltd リウマチの症状改善用飲食品および医薬
JP2007508371A (ja) * 2003-10-15 2007-04-05 ケイエムエスアイ コーポレーション リミテッド 軟骨再生剤としてアピゲニンを含有する骨関節炎治療組成物
JP2016520603A (ja) * 2013-05-29 2016-07-14 ネステク ソシエテ アノニム 軟骨破壊における使用のための組成物
JP2016539090A (ja) * 2013-10-14 2016-12-15 ネステク ソシエテ アノニム 滑膜炎の治療及び予防のための抗炎症植物性栄養素

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis
RU2521227C1 (ru) * 2013-03-28 2014-06-27 Общество С Ограниченной Ответственностью "Парафарм" Композиция для лечения и предупреждения остеоартрита, остеопороза и остеоартроза суставов
JP6742575B2 (ja) 2015-07-02 2020-08-19 株式会社東洋新薬 関節機能改善組成物
KR101794503B1 (ko) * 2016-03-24 2017-11-08 주식회사 티제이씨라이프 강글리오사이드 gm3를 함유하는 연골세포 분화 유도용 조성물 및 이의 이용
CN108938618B (zh) * 2018-06-25 2022-04-22 中国科学院动物研究所 延缓人间充质干细胞衰老的化合物及其应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002284A (ja) * 2001-11-30 2004-01-08 Ezaki Glico Co Ltd リウマチの症状改善用飲食品および医薬
JP2007508371A (ja) * 2003-10-15 2007-04-05 ケイエムエスアイ コーポレーション リミテッド 軟骨再生剤としてアピゲニンを含有する骨関節炎治療組成物
JP2016520603A (ja) * 2013-05-29 2016-07-14 ネステク ソシエテ アノニム 軟骨破壊における使用のための組成物
JP2016539090A (ja) * 2013-10-14 2016-12-15 ネステク ソシエテ アノニム 滑膜炎の治療及び予防のための抗炎症植物性栄養素

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
JIANG, Q., ET AL.: "Lyophilized aqueous extracts of Mori Fructus and Mori Ramulus protect Mesenchymal stem cells from ・", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 17:242, JPN6020032611, 2017, ISSN: 0005165706 *
LIU, Y. C., ET AL.: "Eriodictyol inhibits survival and inflammatory responses and promotes apoptosis in rheumatoid arthri", J CELL BIOCHEM., vol. 120(9) :14628-14635., JPN6020032610, 2019, ISSN: 0005165705 *
MENGFAN, Y., ET AL.: "Morin Exerts Anti-Arthritic Effects by Attenuating Synovial Angiogenesis via Activation of Peroxisom", MOL. NUTR. FOOD RES., vol. 62, e1800202, JPN6020032607, 2018, ISSN: 0005165702 *
WEI, B., ET AL.: "Protective effects of quercetin against inflammation and oxidative stress in a rabbit model of knee", DRUG DEV RES., vol. 80(3), 360-367, JPN6020032606, 2019, ISSN: 0005165701 *
XIAO, S., ET AL.: "Anti-inflammatory effect of hesperidin enhances chondrogenesis of human mesenchymal stem cells for c", JOURNAL OF INFLAMMATION (WEB), vol. 15 : 14, JPN6020032609, 2018, ISSN: 0005165704 *
ZHOU, F., ET AL.: "Isorhamnetin attenuates osteoarthritis by inhibiting osteoclastogenesis and protecting chondrocytes", J CELL MOL MED., vol. 23(6), 4395-4407, JPN6020032608, 2019, ISSN: 0005165703 *

Also Published As

Publication number Publication date
PH12022550260A1 (en) 2022-11-21
CN114206330A (zh) 2022-03-18
CA3147400A1 (en) 2021-02-11
WO2021024801A1 (ja) 2021-02-11
AU2020324628A1 (en) 2022-03-10
EP4008401A1 (en) 2022-06-08
KR20220042403A (ko) 2022-04-05
TW202120078A (zh) 2021-06-01
JP7457713B2 (ja) 2024-03-28
EP4008401A4 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021018704A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021017728A2 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112021017732A2 (https=)
JPWO2021024801A1 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021015080A2 (https=)
BR112021018250A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240315

R150 Certificate of patent or registration of utility model

Ref document number: 7457713

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150